Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1983-1-19
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0091-3952
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
35
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
151-63
|
| pubmed:dateRevised |
2006-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:6128885-Humans,
pubmed-meshheading:6128885-Methods,
pubmed-meshheading:6128885-Nerve Degeneration,
pubmed-meshheading:6128885-Neurotransmitter Agents,
pubmed-meshheading:6128885-Parkinson Disease,
pubmed-meshheading:6128885-Substantia Nigra,
pubmed-meshheading:6128885-Tissue Distribution
|
| pubmed:year |
1982
|
| pubmed:articleTitle |
Biochemical neuroanatomy of the human substantia nigra (pars compacta) in normal and Parkinsonian subjects.
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|